Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC,



Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer
    Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.

PR Newswire

NEW YORK, February 21, 2013

NEW YORK, February 21, 2013 /PRNewswire/ --

Today, National Traders Association announced new research reports
highlighting ResMed Inc. (NYSE: RMD), Zimmer Holdings, Inc. (NYSE: ZMH),
Waters Corporation (NYSE: WAT), Covidien PLC (NYSE: COV), and Medtronic, Inc.
(NYSE: MDT). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

ResMed Inc. Research Report

ResMed is a world leader in the development, manufacturing, and distribution
of medical equipment for treating, diagnosing, and managing sleep-disordered
breathing and other respiratory disorders.  The company has just posted a
quarter ended December 31, 2012 revenue of $376.5 million, a 13% increase over
the previous year. A strong year-over-year growth in both top and bottom lines
also increased revenues locally and abroad. The Full Research Report on ResMed
Inc. - including full detailed breakdown, analyst ratings and price targets -
is available to download free of charge at:
[http://www.nationaltradersassociation.org/r/full_research_report/a31b_RMD]

--

Zimmer Holdings, Inc. Research Report

Global leader in musculoskeletal health, Zimmer Holdings, Inc., has recently
launched the V2F Anterior Fixation System- a new implant system for the
treatment of tumors, thoracolumbar burst fractures, disc degeneration and
other pathologies of the anterior spine. This is Zimmer's first lateral plate
system for the spinal trauma segment. The V2F system offers surgeons greater
flexibility to address the unique anatomy of every patient. The Full Research
Report on Zimmer Holdings, Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.nationaltradersassociation.org/r/full_research_report/cad9_ZMH]

--

Waters Corporation Research Report

Analytic instruments manufacturer, Waters Corporation has done it again as it
introduces new peptide separations chromatography columns, the ACQUITY UPLC,
CSH130 C[18] and XSelect HPLC . These new series of UltraPerformance LC (UPLC)
and high performance liquid chromatography are set to uphold a new standard in
the analysis and purification of peptides. The Full Research Report on Waters
Corporation - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.nationaltradersassociation.org/r/full_research_report/9a02_WAT]

--

Covidien PLC Research Report

Covidien PLC is off to a great start this fiscal 2013, according to Jose E.
Almeida, Chairman, President and CEO.  "In our large Medical Devices segment,
we continued to generate above-market growth in a number of key categories,
including stapling, energy, airway and ventilation. We delivered very strong
growth in emerging markets, as we realized the benefits of our recent
substantial investments in these fast-growing regions." Covidien's net sales
are up 5%, with medical devices sales up 8%. It has also announced completed
acquisition of CV Ingenuity. The Full Research Report on  Covidien PLC -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.nationaltradersassociation.org/r/full_research_report/788a_COV]

--

Medtronic Inc. Research Report

Despite weakness in the U.S. and Europe, Medtronic marks up a 5.7% earnings
growth, with revenues from emerging markets up by 20%. The company looks to
expand sales in countries like China, as the more-developed nations cut back
on expensive medical procedures because of tight budgets. The company recently
spent $816 million for the acquisition of China Kanghui Holdings, a
manufacturer of spine and joint reconstruction products. The Full Research
Report on Medtronic Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.nationaltradersassociation.org/r/full_research_report/1a9b_MDT]

--

Consider National Traders Association

Tired of hearing about the latest, greatest trade opportunity... only to
realize that the ship has long sailed? You need a strong, informative
community in your arsenal. Join the group that has been consistently
identifying momentous situations as they develop - long before they become the
next top news on major financial networks.

Contact: Demi Lapierre
Email: press@NationalTradersAssociation.org
Main: +1-(702)-212-4493

SOURCE National Traders Association
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement